advertisement
According to World Health Organization (WHO), it is not yet clear whether the new COVID-19 variant, 'Omicron' is more transmissible or severe compared to Delta and other previous variants of the virus, WHO said in a statement.
There is currently no information to suggest that symptoms associated with the Omicron variant are different from those from other variants.
In the WHO statement, the agency's Technical Advisory Group on Virus Evolution (TAG-VE) stated, “The number of people testing positive has risen in areas of South Africa affected by this variant, but epidemiologic studies are underway to understand if it is because of Omicron or other factors."
In regards to the effectiveness of vaccines, the WHO is working to understand the potential impact of this variant on the existing countermeasures.
The WHO emphasised, "Vaccines remain critical to reducing severe disease and death, including against the dominant circulating variant, Delta. Current vaccines remain effective against severe disease and death."
Further, the WHO stated that corticosteroids and IL6 receptor blockers will still be effective for managing patients with severe COVID-19.
For the Omicron variant, other treatments will be assessed to see if they are still as effective given the changes to parts of the virus.
Highlighting the inequities in access to vaccines, the WHO said, "In addition, it is vitally important that inequities in access to COVID-19 vaccines are urgently addressed to ensure that vulnerable groups everywhere, including health workers and older persons, receive their first and second doses, alongside equitable access to treatment and diagnostics."
(With inputs from WHO.)
(At The Quint, we question everything. Play an active role in shaping our journalism by becoming a member today.)